martes, 4 de junio de 2019

Reviews from journal of experimental & clinical cancer research

Reviews from journal of experimental & clinical cancer research





Reviews from Journal of Experimental & Clinical Cancer Research

Below is a summary of all reviews published in JECCR. 
Page 1 of 3
  1. Content Type:Review

    Immune checkpoint inhibitor therapy has changed clinical practice for patients with different cancers, since these agents have demonstrated a significant improvement of overall survival and are effective in ma...
    Authors:Francesca Di Modugno, Cristina Colosi, Paola Trono, Giuseppe Antonacci, Giancarlo Ruocco and Paola Nisticò
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:117
    Published on: 
  2. Content Type:Review

    The p38 mitogen-activated protein kinase (p38MAPK) pathway has been implicated in a variety of pathological conditions including inflammation and metastasis. Post-transcriptional regulation of genes harboring ...
    Authors:Sourabh Soni, Prince Anand and Yogendra S. Padwad
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:121
    Published on: 
  3. Content Type:Review

    The extracellular matrix (ECM) plays an important role in cancer progression. It can be divided into the basement membrane (BM) that supports epithelial/endothelial cell behavior and the interstitial matrix (I...
    Authors:Neel I. Nissen, Morten Karsdal and Nicholas Willumsen
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:115
    Published on: 
  4. Content Type:Review

    Novel therapeutic strategies are urgently needed for the treatment of metastatic Urothelial Bladder Cancer. DNA damaging repair (DDR) targeting has been introduced in cinical trials for bladder cancer patients...
    Authors:Daniela Criscuolo, Francesco Morra, Riccardo Giannella, Roberta Visconti, Aniello Cerrato and Angela Celetti
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:91
    Published on: 
  5. Content Type:Review

    PD-1/PD-L1 checkpoint blockades have achieved significant progress in several kinds of tumours. Pembrolizumab, which targets PD-1, has been approved as a first-line treatment for advanced non-small cell lung c...
    Authors:Xin Wang, Gaochao Guo, Hui Guan, Yang Yu, Jie Lu and Jinming Yu
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:87
    Published on: 
  7. Content Type:Review

    Telomeres, the nucleoprotein structures that cap the ends of eukaryotic chromosomes, play important and multiple roles in tumorigenesis. Functional telomeres need the establishment of a protective chromatin st...
    Authors:Stefano Cacchione, Annamaria Biroccio and Angela Rizzo
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:21
    Published on: 
  8. Content Type:Review

    RANKL/RANK/OPG system consists of three essential signaling molecules: i) the receptor activator of nuclear factor (NF)-kB-ligand (RANKL), ii) the receptor activator of NF-kB (RANK), and iii) the soluble decoy...
    Authors:Marco Infante, Alessandra Fabi, Francesco Cognetti, Stefania Gorini, Massimiliano Caprio and Andrea Fabbri
    Citation:Journal of Experimental & Clinical Cancer Research 2019 38:12
    Published on: 
  9. Content Type:Review

    Pancreatic cancer (PC) is among foremost causes of cancer related deaths worldwide due to generic symptoms, lack of effective screening strategies and resistance to chemo- and radiotherapies. The risk factors ...
    Authors:Ramesh Pothuraju, Satyanarayana Rachagani, Wade M. Junker, Sanjib Chaudhary, Viswanathan Saraswathi, Sukhwinder Kaur and Surinder K. Batra
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:319
    Published on: 
  10. Content Type:Review

    Resistance to regulated cell death is one of the hallmarks of human cancers; it maintains cell survival and significantly limits the effectiveness of conventional drug therapy. Leukemia represents a class of h...
    Authors:Xianbo Huang, Feng Xiao, Yuan Li, Wenbin Qian, Wei Ding and Xiujin Ye
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:310
    Published on: 
  12. Content Type:Review

    Most chemotherapeutics elevate intracellular levels of reactive oxygen species (ROS), and many can alter redox-homeostasis of cancer cells. It is widely accepted that the anticancer effect of these chemotherap...
    Authors:Haotian Yang, Rehan M Villani, Haolu Wang, Matthew J Simpson, Michael S Roberts, Min Tang and Xiaowen Liang
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:266
    Published on: 
  13. Content Type:Review

    The mechanism by which c-Myc exerts its oncogenic functions is not completely clear and different hypotheses are still under investigation. The knowledge of the capacity of c-Myc to bind exclusively E-box sequ...
    Authors:Matteo Caforio, Cristina Sorino, Stefano Iacovelli, Maurizio Fanciulli, Franco Locatelli and Valentina Folgiero
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:239
    Published on: 
  14. Content Type:Review

    Non-small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer cases, and it is one of the leading causes of cancer death in both men and women worldwide due to diagnosis in the advanced stag...
    Authors:Hongmei Zheng, Yuting Zhan, Sile Liu, Junmi Lu, Jiadi Luo, Juan Feng and Songqing Fan
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:226
    Published on: 
  15. Content Type:Review

    Phosphatase and tensin homologue (PTEN) triggers a battery of intracellular signaling pathways, especially PI3K/Akt, playing important roles in the pathogenesis of multiple diseases, such as cancer, neurodevel...
    Authors:Wang Li, Ting Zhang, Lianying Guo and Lin Huang
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:223
    Published on: 
  16. Content Type:Review

    Hepatocellular carcinoma (HCC) is a highly malignant disease with a poor prognosis and high mortality due to a low early diagnosis rate, resistance to systemic treatments and progression to late-stage liver di...
    Authors:Jie Li, Xu Han, Xiaona Yu, Zongzhen Xu, Guangsheng Yang, Bingqi Liu and Peng Xiu
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:213
    Published on: 
  17. Content Type:Review

    Circular RNAs (circRNAs) are a type of noncoding RNAs with a closed loop structure. With the development of high-throughput sequencing, massive circRNAs have been discovered in tumorous tissues. Emerging evide...
    Authors:Xuehui Wang and Lin Fang
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:206
    Published on: 
  18. Content Type:Review

    Epithelial-to-mesenchymal transition (EMT) is a complex process involving multiple genes, steps and stages. It refers to the disruption of tight intercellular junctions among epithelial cells under specific co...
    Authors:Long Yan, Feng Xu and Chao-liu Dai
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:203
    Published on: 
  19. Content Type:Review

    The pathophysiological roles and the therapeutic potentials of Myc family are reviewed in this article. The physiological functions and molecular machineries in stem cells, including embryonic stem (ES) cells ...
    Authors:Go J. Yoshida
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:173
    Published on: 
    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research2018 37:285
  20. Content Type:Review

    Biomarkers are an integral part of cancer management due to their use in risk assessment, screening, differential diagnosis, prognosis, prediction of response to treatment, and monitoring progress of disease. ...
    Authors:Michelle H. Townsend, Gajendra Shrestha, Richard A. Robison and Kim L. O’Neill
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:163
    Published on: 
  21. Content Type:Correction

    In the publication of this article [1], there is an error in the Figure caption of Figs. 2, 3 and 4. This has now been included in this correction. The authors declare that these corrections do not change the ...
    Authors:Mei Yi, Junjun Li, Shengnan Chen, Jing Cai, Yuanyuan Ban, Qian Peng, Ying Zhou, Zhaoyang Zeng, Shuping Peng, Xiaoling Li, Wei Xiong, Guiyuan Li and Bo Xiang
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:155
    Published on: 
    The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:118
  22. Content Type:Review

    The natural history of mantle cell lymphoma (MCL) is a continuous process with the vicious cycle of remission and recurrence. Because MCL cells are most vulnerable before their exposure to therapeutic agents, ...
    Authors:Haige Ye, Aakash Desai, Shengjian Huang, Dayoung Jung, Richard Champlin, Dongfeng Zeng, Fangfang Yan, Krystle Nomie, Jorge Romaguera, Makhdum Ahmed and Michael L. Wang
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:150
    Published on: 
  23. Content Type:Review

    The immune system is composed of immune as well as non-immune cells. As this system is a well-established component of human papillomavirus- (HPV)-related carcinogenesis, high risk human papillomavirus (hrHPV)...
    Authors:Marconi Rego Barros Jr, Cristiane Moutinho Lagos de Melo, Maria Luiza Carneiro Moura Gonçalves Rego Barros, Rita de Cássia Pereira de Lima, Antonio Carlos de Freitas and Aldo Venuti
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:137
    Published on: 
  24. Content Type:Review

    Oxidative stress is related to ageing and degenerative diseases, including cancer. However, a moderate amount of reactive oxygen species (ROS) is required for the regulation of cellular signalling and gene exp...
    Authors:Rodrigo Prieto-Bermejo, Marta Romo-González, Alejandro Pérez-Fernández, Carla Ijurko and Ángel Hernández-Hernández
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:125
    Published on: 
  25. Content Type:Review

    Long non-coding RNAs (lncRNAs) refer to functional cellular RNAs molecules longer than 200 nucleotides in length. Unlike microRNAs, which have been widely studied, little is known about the enigmatic role of l...
    Authors:Lei Zhan, Jun Li and Bing Wei
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:120
    Published on: 
  26. Content Type:Review

    Oncogenes derived from the neurotrophin receptor tropomyosin-related kinase TrkA act as drivers in sub-populations of a wide-range of human cancers. This, combined with a recent report that both adult and chil...
    Authors:Antonietta Rosella Farina, Lucia Cappabianca, Pierdomenico Ruggeri, Luciana Gneo, Cristina Pellegrini, Maria-Concetta Fargnoli and Andrew Reay Mackay
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:119
    Published on: 
  27. Content Type:Review

    Cancer stem cells (CSCs) or tumor-initiating cells (TICs) represent a small population of cancer cells with self-renewal and tumor-initiating properties. Unlike the bulk of tumor cells, CSCs or TICs are refrac...
    Authors:Mei Yi, Junjun Li, Shengnan Chen, Jing Cai, Yuanyuan Ban, Qian Peng, Ying Zhou, Zhaoyang Zeng, Shuping Peng, Xiaoling Li, Wei Xiong, Guiyuan Li and Bo Xiang
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:118
    Published on: 
    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research2018 37:155
  28. Content Type:Review

    Immune checkpoints include stimulatory and inhibitory checkpoint molecules. In recent years, inhibitory checkpoints, including cytotoxic T lymphocyte–associated antigen 4 (CTLA-4), programmed cell death protei...
    Authors:Feng Xu, Tianqiang Jin, Yuwen Zhu and Chaoliu Dai
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:110
    Published on: 
  29. Content Type:Review

    Transfer RNAs (tRNAs), traditionally considered to participate in protein translation, were interspersed in the entire genome. Recent studies suggested that dysregulation was observed in not only tRNAs, but al...
    Authors:Shi-qiong Huang, Bao Sun, Zong-ping Xiong, Yan Shu, Hong-hao Zhou, Wei Zhang, Jing Xiong and Qing Li
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:101
    Published on: 
  31. Content Type:Review

    Radioresistance is a major factor leading to the failure of radiotherapy and poor prognosis in tumor patients. Following the application of radiotherapy, the activity of various metabolic pathways considerably...
    Authors:Le Tang, Fang Wei, Yingfen Wu, Yi He, Lei Shi, Fang Xiong, Zhaojian Gong, Can Guo, Xiayu Li, Hao Deng, Ke Cao, Ming Zhou, Bo Xiang, Xiaoling Li, Yong Li, Guiyuan Li…
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:87
    Published on: 
  32. Content Type:Review

    In the advent of Immune Checkpoint inhibitors (ICI) and of CAR-T adoptive T-cells, the new frontier in Oncology is Cancer Immunotherapy because of its ability to provide long term clinical benefit in metastati...
    Authors:Luigi Aurisicchio, Matteo Pallocca, Gennaro Ciliberto and Fabio Palombo
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:86
    Published on: 
  33. Content Type:Review

    The epidermal growth factor receptor (EGFR) plays important roles in cell survival, growth, differentiation, and tumorigenesis. Dysregulation of the EGFR is a common mechanism in cancer progression especially ...
    Authors:Meng-Shih Weng, Jer-Hwa Chang, Wen-Yueh Hung, Yi-Chieh Yang and Ming-Hsien Chien
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:61
    Published on: 
  34. Content Type:Review

    With cancer stem cells (CSCs) became the research hotspot, emerging studies attempt to reveal the functions of these special subsets in tumorigenesis. Although various approaches have been used in CSCs researc...
    Authors:Y. T. Luo, J. Cheng, X. Feng, S. J. He, Y. W. Wang and Q. Huang
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:38
    Published on: 
  35. Content Type:Review

    Current treatment for acute myeloid leukemia (AML) is less than optimal, but increased understanding of disease pathobiology and genomics has led to clinical investigation of novel targeted therapies and ratio...
    Authors:Silvia Boffo, Angela Damato, Luigi Alfano and Antonio Giordano
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:36
    Published on: 
  37. Content Type:Review

    Since Salinomycin (Sal) emerged its ability to target breast cancer stem cells in 2009, numerous experiments have been carried out to test Sal’s anticancer effects. What deserve to be mentioned is that Sal can...
    Authors:Jiang Jiang, Hailong Li, Eskandar Qaed, Jing Zhang, Yushu Song, Rong Wu, Xinmiao Bu, Qinyan Wang and Zeyao Tang
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:26
    Published on: 
  38. Content Type:Review

    Antibody-Drug Conjugates (ADCs) are a class of cancer therapeutics that combines antigen specificity and potent cytotoxicity in a single molecule as they are comprised of an engineered antibody linked chemical...
    Authors:Cécile Chalouni and Sophia Doll
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:20
    Published on: 
  39. Content Type:Review

    Cancer remains as one of the leading cause of death worldwide. The development of cancer involves an intricate process, wherein many identified and unidentified factors play a role. Although most studies have ...
    Authors:Nyanbol Kuol, Lily Stojanovska, Vasso Apostolopoulos and Kulmira Nurgali
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:5
    Published on: 
  40. Content Type:Review

    Osteosarcoma (OS) is the most common primary malignant tumor of bone, which preferentially develops lung metastasis. Although standard chemotherapy has significantly improved long-term survival over the past f...
    Authors:Angela De Luca, Lavinia Raimondi, Francesca Salamanna, Valeria Carina, Viviana Costa, Daniele Bellavia, Riccardo Alessandro, Milena Fini and Gianluca Giavaresi
    Citation:Journal of Experimental & Clinical Cancer Research 2018 37:2
    Published on: 
  41. Content Type:Review

    Telomeres are specialized nucleoprotein structures responsible for protecting chromosome ends in order to prevent the loss of genomic information. Telomere maintenance is required for achieving immortality by ...
    Authors:Luca Pompili, Carlo Leonetti, Annamaria Biroccio and Erica Salvati
    Citation:Journal of Experimental & Clinical Cancer Research 2017 36:189
    Published on: 
  42. Content Type:Review

    Mantle cell lymphoma (MCL) is an aggressive disease, with poor prognosis and a limited survival. However, some patients with indolent MCL can survive beyond 7~10 years. These patients remain largely asymptomat...
    Authors:Haige Ye, Aakash Desai, Dongfeng Zeng, Krystle Nomie, Jorge Romaguera, Makhdum Ahmed and Michael L. Wang
    Citation:Journal of Experimental & Clinical Cancer Research 2017 36:185
    Published on: 
  43. Content Type:Review

    Glioblastoma Multiforme is the deadliest type of brain tumor and is characterized by very poor prognosis with a limited overall survival. Current optimal therapeutic approach has essentially remained unchanged...
    Authors:Claudia Abbruzzese, Silvia Matteoni, Michele Signore, Luca Cardone, Kavindra Nath, Jerry D. Glickson and Marco G. Paggi
    Citation:Journal of Experimental & Clinical Cancer Research 2017 36:169
    Published on: 
  44. Content Type:Review

    CircRNAs are a class of RNA molecules that structurally form closed loops. CircRNAs are abundant in eukaryotic transcripts and show certain levels of tissue and cell specificity. CircRNAs have been suggested t...
    Authors:Yu Zhang, Wei Liang, Peng Zhang, Jingyan Chen, Hui Qian, Xu Zhang and Wenrong Xu
    Citation:Journal of Experimental & Clinical Cancer Research 2017 36:152
    Published on: 
  45. Content Type:Review

    The increasing use of genomics to define the pattern of actionable mutations and to test and validate new therapies for individual cancer patients, and the growing application of liquid biopsy to dynamically t...
    Authors:Nicola Silvestris, Gennaro Ciliberto, Paolo De Paoli, Giovanni Apolone, Maria Luisa Lavitrano, Marco A. Pierotti and Giorgio Stanta
    Citation:Journal of Experimental & Clinical Cancer Research 2017 36:128
    Published on: 
  46. Content Type:Review

    Elucidation of mechanisms regulating bone metastasis has progressed significantly in recent years and this has translated to many new therapeutic options for patients with bone metastatic cancers. However, the...
    Authors:Andrew S. Gdowski, Amalendu Ranjan and Jamboor K. Vishwanatha
    Citation:Journal of Experimental & Clinical Cancer Research 2017 36:108
    Published on: 
  48. Content Type:Review

    Worldwide breast cancer is the most common cancer in women. For many years clinicians and the researchers are examining and exploring various therapeutic modalities for breast cancer. Yet the disease has remai...
    Authors:Urmila Banik, Subramani Parasuraman, Arun Kumar Adhikary and Nor Hayati Othman
    Citation:Journal of Experimental & Clinical Cancer Research 2017 36:98
    Published on: 
  49. Content Type:Review

    CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a prokaryotic adaptable immune mechanism used by many bacteria and archaea to protect themselves from foreign nucleic acids. This complex s...
    Authors:A. Biagioni, A. Chillà, E. Andreucci, A. Laurenzana, F. Margheri, S. Peppicelli, M. Del Rosso and G. Fibbi
    Citation:Journal of Experimental & Clinical Cancer Research 2017 36:80
    Published on: 
  50. Content Type:Review

    The immune response is a key factor in the fight against HPV infection and related cancers, and thus, HPV is able to promote immune evasion through the expression of oncogenes. In particular, the E5 oncogene i...
    Authors:Antonio Carlos de Freitas, Talita Helena Araújo de Oliveira, Marconi Rego Barros Jr. and Aldo Venuti
    Citation:Journal of Experimental & Clinical Cancer Research 2017 36:71
    Published on: 
Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)